1H NMR spectroscopy for the prediction of therapeutic outcome in patients with fulminant hepatic failure

Varsha Saxena, Ashish Gupta, G. A.Nagana Gowda, Rajan Saxena, S. K. Yachha, C. L. Khetrapal

Research output: Contribution to journalArticlepeer-review

Abstract

A high-resolution 1H NMR study of serum and urine of fulminant hepatic failure patients (n = 22) [surviving (n = 12) and non-surviving (n = 10)] is reported. Glutamine in serum and urine glutamine:creatinine ratio were higher in non-surviving patients compared with surviving patients [serum glutamine, 3.08 (1.69-7.11) vs 0.56 (0.34-0.99) mM, median and range; p = 0.0001 and urine glutamine:creatinine ratio, 1.72 (0.24-7.76) vs 0.39 (0.1-0.84), p = 0.1], and urine urea:creatinine ratio was higher in surviving patients compared with non-surviving patients [10.83 (0.2-22.6) vs 2.09 (0.96-4.0), P = 0.002]. On the other hand, no significant differences were found in the conventionally employed clinical parameters such as serum alanylaminotransferase, aspartylaminotransferase and bilirubin except prothrombin time (p = 0.02). The difference in serum glutamine and urine urea was significant in the two categories of patients and distinctly different values of serum glutamine for both the categories of patients correctly predicted the outcome. These results promise immense potential for NMR spectroscopy in rapidly deciding on the need for advanced therapeutic intervention such as artificial liver support or emergency liver transplantation in FHF.

Original languageEnglish (US)
Pages (from-to)521-526
Number of pages6
JournalNMR in biomedicine
Volume19
Issue number5
DOIs
StatePublished - Aug 1 2006

Keywords

  • Fulminant hepatic failure
  • Glutamine
  • H NMR
  • Liver disease
  • Serum
  • Urine
  • urea

ASJC Scopus subject areas

  • Molecular Medicine
  • Radiology Nuclear Medicine and imaging
  • Spectroscopy

Fingerprint

Dive into the research topics of '<sup>1</sup>H NMR spectroscopy for the prediction of therapeutic outcome in patients with fulminant hepatic failure'. Together they form a unique fingerprint.

Cite this